chrisvoncsefalvay/vaers-outcomes huggingface dataset:
sore throat; pain/aches; he said he had a loss of taste that started yesterday, 24Jan2021, but he did not have a complete loss of taste; Coughing; Dry throat; Muscle pain; This is a spontaneous report from a contactable consumer reported for himself. A 74-years-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3246 and expiry date: Apr2021), via an unspecified route of administration on left arm on 18Jan2021 (11:00-11:10 AM) at SINGLE DOSE for covid-19 immunisation. Medical history included none. The patient's concomitant medications were not reported. The patient previously took flu shot on 06Jan2021 with no adverse event. The patient received 1st dose on 18Jan2021, unknown date the patient started experiencing "what sounded like flu": sore throat, pain/aches. He said 2 days ago on 23Jan2021, he had developed a dry throat, coughing, and muscle pain. He said everything else is easing up (clarified as his dry throat and muscle pain), except for his cough. He said he is supposed to have a procedure tomorrow to replace his defibrillator and is wondering if it is OK for him to go ahead with the procedure. Reported he had a loss of taste that started yesterday on 24Jan2021. He said he did not have a complete loss of taste. He said he does not have a strong sense of taste now. He said he could barely taste his coffee this morning, clarifying that his coffee tasted like he was drinking hot water. Declined any reported he had taken some over-thecounter pain killers, like Ibuprofen, in the past couple of weeks. He said he is not a big medication person, except for his heart medication, and the Ibuprofen is something he previously had in his house. The caller clarified his doctor stated he would test him for the COVID-19 Virus tomorrow on 26Jan2021 before his surgery. Reported he had blood work done on 06Jan2021, the same day he had a flu shot. He clarified he did not have any side effects from the flu vaccine on 06Jan2021. He said he never has side effects when he gets vaccines. Reported he had blood work done again on Friday, 22Jan2021, when he went for his preregistration for his surgery that is scheduled on 26Jan2021. Outcome of the events dry throat, and muscle pain was recovering, outcome of the event loss of taste and coughing was not recovered, outcome of the other events was unknown.
Ringing in right ear. Onset 4 hours after injection. Ringing persists until now.
Patient was given the wrong vaccine.  Patient was due for Dtap  and was given TDAP .
rash on face & swelling around eyes are reported in a pt receiving 1 dose of fluogen on 4NOV93 & that evening pt exp rash on the skin around the eyes accompanied by swelling around the eyes which lasted 2 days;
This spontaneous report as received from a medical assistant refers to a patient of unknown age. On 25-JUN-2013, the patient was vaccinated with GARDASIL (lot number and expiry date not provided) (route not provided) dose 2. The medical assistant reported that the first dose of GARDASIL was administered on 28-APR-2008 and the second dose on 25-JUN-2013. No adverse effect reported. The outcome of first dose of GARDASIL was administered on 28-APR-2008 and the second dose on 25-JUN-2013 and no adverse effect is unknown. The reporter considered first dose of GARDASIL was administered on 28-APR-2008 and the second dose on 25-JUN-2013 and no adverse effect to be not related to GARDASIL. Additional information has been requested.
first dose of Shingirx on 30Nov2020 / was infected with Covid-19; This case was reported by a pharmacist via call center representative and described the occurrence of covid-19 virus test positive in a 77-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th November 2020, the patient received the 1st dose of Shingrix. On an unknown date, several months after receiving Shingrix, the patient experienced covid-19 virus test positive. On an unknown date, the outcome of the covid-19 virus test positive was unknown.   It was unknown if the reporter considered the covid-19 virus test positive to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was reported as 77 years. The patient after receiving first dose of shingrix few months later was infected with Covid-19. The Vaccine Administration Facility is the same as Primary Reporter The reporter Consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020252515:same reporter
1 episode of vomiting and diarrhea 12 hours after administration.  Afebrile.  No other events of nausea/vomiting yet during pregnancy. 4 weeks, 4 days pregnant. EDD 8/27/21.
Sneezing, congestion, swallowing freq. weak nausea - approx. a minute and half - called mom (parents) this AM - but was unable to get update.
Heat; Reddness; Swelling; Pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Heat), VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Pain) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included Synthroid 100ug for Hypothyroidism.    On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Aug-2021, the patient experienced VACCINATION SITE WARMTH (Heat), VACCINATION SITE ERYTHEMA (Reddness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Pain). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. On 20-Aug-2021, VACCINATION SITE WARMTH (Heat), VACCINATION SITE ERYTHEMA (Reddness), VACCINATION SITE SWELLING (Swelling) and VACCINATION SITE PAIN (Pain) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment- Icepack to alleviate local reaction   This case was linked to MOD-2021-322356 (Patient Link).
Shingles - Herpes Zoster Fatigue, febrile, malaise,
diagnosed with COVID-19 after first dose of Moderna COVID-19 vaccine; very ill; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 after first dose of Moderna vaccine and ILLNESS in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced ILLNESS. On 14-Jan-2021, the patient experienced COVID-19 diagnosed after first dose of Moderna vaccine. At the time of the report, COVID-19 diagnosed after first dose of Moderna COVID-19 vaccine had resolved and ILLNESS (very ill) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, SARS-CoV-2 test Positive.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Patient did not take any concomitant medications.  Patient received antibody infusion for COVID-19.
Sudden onset cough, shortness of breath, and wheezing. A fever of 100.6 was noted but unsure as to when that occurred as I did not have chills. Feber has subsided.  Cough, shortness of breath and intermittent wheezing remain as well as some chest pressure, sore throat, headache and chills. Coughing fits are bad enough to cause urinary incontinence but I did give birth 4 months ago so this may not be significant. No signs of allergic reactive such as redness, urticaria or swelling.
ITCHING; JOINT PAIN; HEADACHE; ADMINISTERED HALF DOSE OF JANSSEN COVID-19 VACCINE; OFF LABEL USE; ANAPHYLACTIC SHOCK; This spontaneous report received from a patient concerned a 48 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included mast cell activation syndrome, non smoker, and non alcoholic, and other pre-existing medical conditions included no drug abuse or illicit drug usage. The patient experienced drug allergy when treated with moxifloxacin hydrochloride, azithromycin, methylprednisolone, phenelzine, and bupropion hydrochloride for drug used for unknown indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, one total, administered on right deltoid on 17-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included Benadryl continuous IV - 300 mg/24 hours for drug used for unknown indication and takes rescue Benadryl - 50 mg as needed for drug used for unknown indication. On 17-JUN-2021, Doctor administered half dose of vaccine because of patient's condition (mast cell activation syndrome). On 17-JUN-2021, patient went into anaphylactic shock 3 minutes later after vaccination and was administered Epi-pen (epinephrine). On 17-JUN-2021, the patient experienced headache. On 19-JUN-2021, the patient experienced itching and joint pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from anaphylactic shock, and headache on 17-JUN-2021, was recovering from itching, had not recovered from joint pain, and the outcome of administered half dose of Janssen covid-19 vaccine and off label use was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210660183- Covid-19 vaccine ad26.cov2.s- Anaphylactic shock, itching. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY 20210660183- Covid-19 vaccine ad26.cov2.s- Joint pain, headache. This event(s) is labeled per RSI and is therefore considered potentially related.
Developed low grade fever, congestion and significant emotional lability that lasted 4.5 days post vaccination.  Improved on day 5.
Chills; pain in arm soar for three days; significant loss of hair; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 14 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 04Aug2021 12:00 (Lot number: EWO167) at the age of 14 years as dose 2, single and (Lot number: EWO167) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Sickle cell disease (SS)" (unspecified if ongoing); "asthma( mild)" (unspecified if ongoing); "known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: HYDROXYUREA; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; ALBUTEROL [SALBUTAMOL]; FLOVENT. The following information was reported: CHILLS (non-serious) with onset 01Sep2021, outcome "recovered" (04Sep2021), described as "Chills"; PAIN IN EXTREMITY (non-serious) with onset 01Sep2021, outcome "recovered" (04Sep2021), described as "pain in arm soar for three days"; ALOPECIA (non-serious) with onset 01Sep2021, outcome "not recovered", described as "significant loss of hair". Therapeutic measures were not taken as a result of chills, pain in extremity, alopecia.  Additional information: Facility type vaccine: School or Student Health Clinic. Other vaccine in four weeks: No. Other medications in two weeks coded under concomitant medications. Covid prior vaccination and tested post vaccination: No.  No follow-up attempts are possible. No further information is expected.
measles rash, onset 31DEC96 lasted approx 1-2wk, fever & irritability on & off from 28DEC96 thru 17JAN97, swelling of the lymph glands 31DEC96 to 17JAN97-to see MD because head felt all bumpy, swelling of the glands in cheeks & under jaw;
Developed chest pain (like someone is sqqueezing my heart) the morning after my shot. Chills and fever that same night. Severe Headaches and bodyaches for 5 days at the time of this record.
Started having joint issues, headaches...after series completed, had a butterfly rash...Tested negative for rheumatoid, which does run in family....when 18-diagnosed and tested positive for both discoid lupus and systemic lupus...no family history of.
Pt reported felling hot. Provided with water, denies shortness of breath or difficulty, denies tingling of throat. Provided juice, pt reported feeling better and requested to leave.
This spontaneous report was received from a physician via a company representative refers to a 13 year old male patient. On an unknown date the patient was vaccinated with GARDASIL (dose, route and lot # were not provided). The patient was also vaccinated concomitantly with VAQTA (dose, route and lot # were not provided). The reporter stated that 2 to 3 days after the patient was vaccinated with GARDASIL and VAQTA, he developed hives. The physician gave to the patient unspecified antihistamines to treat the reaction. The reporter stated that the doctor said the hives were all cleared up now. Additional information has been requested.
pt rcvd vax; exp grand mal seizure 10-11 hrs after vax; pt unresponsive for 30mn; pt taken to hosp; became cyanotic & breathing stopped for few sec; some rt side paralysis;
A 17 year old patient was given the Janssen vaccine instead of Pfizer.  Janssen is not approved for under 18 years of age.  The patient was monitored for 30 minutes after vaccination with no adverse effect.  Patient's legal guardian was present and aware of the situation.
My upper left arm has a large, hard, swollen, hot red patch about 5 inches by 5 inches.  It is a bit tender to the touch and very swollen.
vaginal bleeding.  Pt reports LMP 28Feb and started having vaginal bleeding on 12Mar and has variable light to heavier bleeding since then. patient also received J&J COVAX yesterday and has fever,and headache, reports improvement with excedrin. 24 yo f c/o ongoing vaginal bleeding w/clots x1wk w/irregular menstrual cycle timing; Pt states LMP 28FEB2021, states was regular w/o heavy flow; Pt states approx 7d ago sudden onset of vaginal bleeding, however tapered off slowly over next several days, then increased again this AM, states has used 1x pad over last 4hrs; Pt states mild abd cramping radiating to lower back b/l, c/w sx's experience during child birth; Pt denies any fevers/ns/chills, nvd, urinary sx's
I did not have a reaction to the vaccine. I had a runny nose with a fever a couple of days before testing positive. I tested positive for COVID-19 on 11/17/2022. I contacted my doctor, but I was not a candidate for Paxlovid because of heart issues. I was prescribed Molnupiravir which helped with my symptoms.
Partial dose given. Vaccine leaked at hub. Administered 2nd dose in opposite arm after calling office to get okay from nurse to administer 2nd dose. Partial dose given IM in right deltoid. Second complete dose given IM in left deltoid.
Information has been received from a registered nurse concerning a patient who were vaccinated with a dose of VARIVAX (Oka/Merck) and developed hives. No other information was available. It was noted that the above information was on a fax that the office received from the another hospital. This patient was not a patient from this office. Unspecified medical attention was sought. There was no product quality complaint. This event was considered an other medical event by the reporter. This is one report of several from the same source. Additional information has been requested.
very sick with asthma and bronchitis/asthma; little allergy; Initial information received on 11-Mar-2021 regarding an unsolicited valid non-serious case received from a patient.  This case involves an unknown age female patient who was very sick with asthma and bronchitis/asthma and little allergy, while she was treated with dupilumab (Dupixent), delivered via dupilumab pre-filled pen and influenza vaccine.  The patient's past medical history, medical treatment(s), concomitant medication(s) and family history were not provided. At the time of the event, the patient had ongoing allergies to egg whites and 10-15 other things.   Since an unknown date, the patient started taking dupilumab (strength: 300 mg; formulation, dosage, route, frequency, batch number, expiry: unknown) used for her long-time skin condition of 35 years, delivered via dupilumab prefilled pen. In the context of COVID19 crisis, the batch number and expiration date were not requested. On an unknown date, patient received a influenza vaccine (flu shot) (did not remember the specific name of the flu shot that she received) (strength, formulation, dosage, route, frequency, batch number, expiry: unknown) used for an unknown indication. On an unknown date, after unknown latency, flu shot made her very sick with asthma and bronchitis (asthma). She was told by her doctors that she should not receive flu shots in the future due to that experience. Since an unknown date, after unknown latency, patient happened to have asthma and had noticed that dupilumab had also helped her asthma. She said dupilumab really worked for her and had made her more comfortable. On an unknown date, after unknown latency, patient still had a little allergy (hypersensitivity), but she could deal with that. Patient uses the dupilumab pen and wanted to know if she could get the COVID (coronavirus disease) vaccine because she was scared as she could not get the flu vaccine due to her allergies to egg whites and 10-15 other things.   First time product used: No   Action taken: unknown for asthma and hypersensitivity with dupilumab; not applicable for asthma and hypersensitivity with influenza vaccine.  It was not reported if the patient received a corrective treatment.  Outcome: unknown for asthma but not recovered for little allergy.
Right hand and joints swelled 2 days after vaccine. Pt tried multiple therapies no relief.
This case was reported by a consumer via call center representative and described the occurrence of headache in a 74-year-old female patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of headache (see case: US2018173656). On 19th September 2018, the patient received the 2nd dose of SHINGRIX. On 19th September 2018, less than a day after receiving SHINGRIX, the patient experienced headache, diarrhea and nausea. On 20th September 2018, the patient experienced dizziness and tiredness. On an unknown date, the outcome of the headache, dizziness, nausea and tiredness were not recovered/not resolved and the outcome of the diarrhea was recovered/resolved. It was unknown if the reporter considered the headache, dizziness, diarrhea, nausea and tiredness to be related to SHINGRIX. Additional details were reported as follows: The patient received SHINGRIX into left arm. The headache and nausea presented the evening of vaccination. On 20th September 2018, 1 day after receiving SHINGRIX the patient experienced dizziness and she was tired. The patient had not been able to eat very much due to the nausea. The side effects were much more severe. This case has been linked to the US2018173656, reported by the same reporter.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 19 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 02Dec2021 10:00 (Lot number: FJ8762) at the age of 19 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "struggled like heart pain for most of my life" (unspecified if ongoing), notes: struggled like heart pain for most of my life. Concomitant medication(s) included: LEVOTHYROXINE; CONCERTA; FINASTERIDE. Vaccination history included: Bnt162b2 (Dose 1), administration date: 21Mar2021, when the patient was 18 years old, for COVID-19 Immunization, reaction(s): "little swelling in the arm"; Bnt162b2 (Dose 2), administration date: 05Apr2021, when the patient was 18 years old, for COVID-19 Immunization, reaction(s): "headache", "pain in my chest like left side of my chest", "body started to ache", "arm aching". The following information was reported: IMMUNISATION (non-serious) with onset 02Dec2021, outcome "unknown", described as "booster shot"; PAIN (non-serious) with onset 02Dec2021, outcome "unknown", described as "it hurts"; CONDITION AGGRAVATED (non-serious) with onset 02Dec2021, outcome "unknown", described as "it's just like it's definitely worse than when I had my second shot". Therapeutic measures were not taken as a result of pain, condition aggravated. Additional information: Prior vaccination (4 Weeks) were none. Patient stated, It might be worst, I am not saying it definitely is. It just hurts. I am just in pain right now. No follow-up attempts are possible. No further information is expected.
Information has been received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history and drug allergies were not reported. On 30-OCT-2013, the patient was vaccinated with the first dose of PNEUMOVAX23 (lot #, expiration date, dose and strength unknown). On 21-OCT-2015 the patient was vaccinated with the second dose of PNEUMOVAX23 (lot # L013428 with expiration date of 03-FEB-2017, dose and strength unknown). No adverse effect reported. Additional information has been requested.
On or around May 7th I started to experience a significant decrease in blood glucose levels. Insulin requirements drastically were reduced over the following 7 days. Long acting insulin was reduced by 35% and short acting insulin by 75% within a 7 day period. I reported this phenomenon to my endocrinologist, on May 11. I also reported this to where I am a research participant in their study.  Neithe researchers or my endocrinologist were able to provide an explanation. Therefore, I requested a C-Peptide test which came back negative. I wanted to report this as a possible correlation between the building of Covid antibodies/immune cells and depletion of glucose in type 1 diabetes. Thank you.
I walk daily in hills around my neighbor with my dog.  I noticed it being more taxing to walk uphill after having the vaccination.  Also I do daily dance exercise classes for an hour.  I could do it fully no issues but after vaccination I have a harder time completing the class with 100% participation all the way to the end.  I noticed my feet feeling numbness in toes after lots of walking as well.  Never had this happen before though I walk daily and occasionally all day at the local adjustment park.
Shortly after receiving the vaccine, pt experienced tongue tingling, tachycardia (160's) and chest pressure. ICC was called and pt was evaluated in ICC, treated, and was able to go home.